Differential effects of Na+-K+ ATPase blockade on cortical layer V neurons.
Sodium-potassium ATPase ('Na(+)-K(+) ATPase') contributes to the maintenance of the resting membrane potential and the transmembrane gradients for Na(+) and K(+) in neurons. Activation of Na(+)-K(+) ATPase may be important in controlling increases in intracellular sodium during periods of increased neuronal activity. Down-regulation of Na(+)-K(+) ATPase activity is implicated in numerous CNS disorders, including epilepsy. Although Na(+)-K(+) ATPase is present in all neurons, little is known about its activity in different subclasses of neocortical cells. We assessed the physiological properties of Na(+)-K(+) ATPase in fast-spiking (FS) interneurons and pyramidal (PYR) cells to test the hypothesis that Na(+)-K(+) ATPase activity would be relatively greater in neurons that generated high frequency action potentials (the FS cells). Whole-cell patch clamp recordings were made from FS and PYR neurons in layer V of rat sensorimotor cortical slices maintained in vitro using standard techniques. Bath perfusion of Na(+)-K(+) ATPase antagonists (ouabain or dihydro-ouabain) induced either a membrane depolarization in current clamp, or inward current under voltage clamp in both cell types. PYR neurons were divided into two subpopulations based on the amplitude of the voltage or current shift in response to Na(+)-K(+) ATPase blockade. The two PYR cell groups did not differ significantly in electrophysiological properties including resting membrane potential, firing pattern, input resistance and capacitance. Membrane voltage responses of FS cells to Na(+)-K(+) ATPase blockade were intermediate between the two PYR cell groups (P < 0.05). The resting Na(+)-K(+) ATPase current density in FS interneurons, assessed by application of blockers, was 3- to 7-fold larger than in either group of PYR neurons. Na(+)-K(+) ATPase activity was increased either through direct Na(+) loading via the patch pipette or by focal application of glutamate (20 mM puffs). Under these conditions FS interneurons exhibited the largest increase in Na(+)-K(+) ATPase activity. We conclude that resting Na(+)-K(+) ATPase activity and sensitivity to changes in internal Na(+) concentration vary between and within classes of cortical neurons. These differences may have important consequences in pathophysiological disorders associated with down-regulation of Na(+)-K(+) ATPase and hyperexcitability within cortical networks.
Anderson
Trent R
TR
Neurology and Neurological Sciences, Stanford University, CA 94305, USA.
Huguenard
John R
JR
Prince
David A
DA
D000200:Action Potentials / Q000187:drug effects / Q000502:physiology*; D000818:Animals; D000831:Animals, Newborn; D002540:Cerebral Cortex / Q000166:cytology / Q000187:drug effects / Q000201:enzymology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D009474:Neurons / Q000187:drug effects / Q000201:enzymology*; D010042:Ouabain / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors* / Q000378:metabolism*
D004791:Enzyme Inhibitors; D010042:Ouabain; D000254:Sodium-Potassium-Exchanging ATPase
Nat Neurosci. 2007 Feb;10(2):196-205
17220883
J Neurophysiol. 2002 Nov;88(5):2713-25
12424306
J Neurophysiol. 1993 Jul;70(1):387-96
8395585
J Neurophysiol. 2004 Oct;92(4):2283-94
15381746
J Neurophysiol. 2000 Oct;84(4):1869-80
11024079
J Neurophysiol. 1999 Sep;82(3):1295-302
10482748
Trends Neurosci. 1990 Mar;13(3):99-104
1691879
Arch Neurol. 1975 Aug;32(8):549-54
125576
Cell Mol Neurobiol. 1991 Apr;11(2):253-62
1851465
J Biol Chem. 2006 Jul 14;281(28):19709-19
16698801
J Neurosci. 1991 Feb;11(2):381-91
1846906
J Comp Neurol. 1993 Sep 1;335(1):92-108
8408775
Brain Res. 2003 Jul 11;977(2):284-9
12834889
Neurosci Lett. 1994 Jul 4;175(1-2):117-20
7970191
J Neurophysiol. 1985 Oct;54(4):782-806
2999347
J Neurophysiol. 1982 Dec;48(6):1302-20
6296328
Cell. 2006 Apr 21;125(2):359-69
16630822
Neurochem Int. 1996 May-Jun;28(5-6):497-500
8792330
Epilepsy Res. 1994 Mar;17(3):221-31
8013444
J Neurosci. 2003 Oct 22;23(29):9664-74
14573546
J Physiol. 1997 Jul 15;502 ( Pt 2):387-95
9263918
J Physiol. 2007 Dec 1;585(Pt 2):491-505
17947306
Brain Res Dev Brain Res. 1992 Jan 17;65(1):101-14
1372539
J Neurophysiol. 1993 Apr;69(4):1276-91
8492163
J Neurochem. 1989 Jan;52(1):193-200
2535710
Brain Res. 1993 Dec 17;631(1):1-11
8298981
J Neurosci. 1997 Aug 15;17(16):6352-64
9236244
Brain Res Brain Res Rev. 1991 Sep-Dec;16(3):283-300
1665097
Biochemistry. 1979 May 29;18(11):2308-15
221003
J Neurosci. 1995 Dec;15(12):8234-45
8613757
J Neurosci. 1997 May 15;17(10):3894-906
9133407
Prog Neurobiol. 1981;17(3):141-84
6275454
J Exp Biol. 2006 Jun;209(Pt 12):2304-11
16731806
J Neurophysiol. 2004 Jan;91(1):239-47
14715719
J Bioenerg Biomembr. 1992 Jun;24(3):263-70
1328175
Proc Natl Acad Sci U S A. 1990 Feb;87(3):1178-82
2153972
J Physiol. 2009 Feb 15;587(Pt 4):713-9
19218620
J Neurophysiol. 2000 May;83(5):2916-30
10805688
Can J Biochem. 1971 Nov;49(11):1217-24
4257414
J Assoc Physicians India. 2002 Mar;50:400-6
11922232
J Neurosci. 2004 Oct 27;24(43):9598-611
15509747
Am J Physiol Cell Physiol. 2000 Sep;279(3):C541-66
10942705
Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8874-9
11438685
J Physiol. 1998 Feb 1;506 ( Pt 3):715-30
9503333
J Gen Physiol. 1989 Sep;94(3):511-37
2607333
Nature. 1984 Aug 23-29;310(5979):685-7
6147755
J Neurophysiol. 1986 Aug;56(2):507-22
2428952
J Cereb Blood Flow Metab. 1999 Sep;19(9):1051-9
10478657
Brain Res. 1992 Oct 16;593(2):239-44
1333345
J Neurophysiol. 2002 Dec;88(6):2963-78
12466422
J Neurophysiol. 1992 Jul;68(1):28-35
1355527
Front Biosci. 2005 Sep 01;10:2373-96
15970502
Am J Physiol. 1998 Nov;275(5):F633-50
9815123
Biol Pharm Bull. 2002 Mar;25(3):291-301
11913521
J Neurophysiol. 1994 May;71(5):1762-73
8064347
Brain Res Mol Brain Res. 1991 May;10(2):139-50
1649367
Clin Exp Pharmacol Physiol. 2002 Nov;29(11):1018-23
12366395
J Neurophysiol. 2005 Feb;93(2):963-79
15456803
Brain Res. 2007 Mar 23;1138:203-7
17270150